Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Gymnemagenin
Cat. No.:
OB0425LY-330
Appearance:
Solid
Purity:
99.44%
Identity:
Confirmed by NMR, HPLC, and MS.
Size:
Add to basket
Product Overview
Description:
Gymnemagenin, derived from Gymnema sylvestre, is known for its potential anti-diabetic properties by reducing sugar cravings and regulating blood glucose levels.
Synonyms:
22467-07-8; (3R,4R,4aR,5S,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-4a,9-Bis(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-3,4,5,10-tetrol
CAS No.:
22467-07-8
Compound CID:
10051937
Formula:
C30H50O6
Formula Weight:
506.71
Specification
Source:
G. sylvestre
Target:
Antibiotic
Pathway:
Anti-infection
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
Gymnemagenin can be used as an agent for diabetes and obesity.
